HPV immune cells (CTLs) for HPV treatment
Part of Infections clinical trials.
This trial tests whether specially grown immune cells (HPV-CTLs) can fight HPV by targeting the virus. It is for people whose HPV infection has not responded to standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an active HPV infection confirmed by DNA test or biopsy.
- You have tried standard treatments or they are not right for you.
- You are under 75 years old.
- You are not taking penicillin or strong antibiotics.
- Your blood cell counts and liver/kidney function are within safe ranges.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a lab-made treatment using your own immune cells (T cells) to target HPV-related throat cancers. It aims to reduce cancer by directing your immune system against HPV16/HPV18 and a protein called survivin.
This Phase 1/2 trial tests a one-time infusion of special immune T cells made to recognize your HPV16 tumor. It may help your body attack the cancer, while researchers closely monitor safety and early effectiveness.
This trial tests a new treatment using your own immune cells (called T cells) that are modified to target HPV-positive cancer cells. It may be an option if you have advanced cervical, head/neck, anal, penile, vulvar, or vaginal cancer that is HPV16 or HPV52 positive and has progressed after standard therapy.
This Phase 2 trial tests an immune-cell treatment (E7 TCR T cells) designed to attack cancers caused by HPV type 16. It may help people whose HPV-16+ cancer has come back or not responded to standard treatment.
This trial tests a new treatment called SCG142 TCR-T cells for cancers caused by HPV. The therapy uses your own immune cells to fight the tumor. It may help if other treatments haven't worked or are not available.
This trial tests whether a blood test measuring HPV DNA can help doctors decide the best treatment for HPV-positive throat cancer. The goal is to use this information to guide whether patients need immunotherapy (a drug called pembrolizumab) after their initial treatment.
Hear when a new Human Papilloma Virus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.